IgA Nephropathy Benefits from Compound K Treatment by Inhibiting NF-κB/NLRP3 Inflammasome and Enhancing Autophagy and SIRT1-Reference-Cited by-同舟云学术

IgA Nephropathy Benefits from Compound K Treatment by Inhibiting NF-κB/NLRP3 Inflammasome and Enhancing Autophagy and SIRT1

Published:2020-06-01 Issue:1 Volume:205 Page:202-212
ISSN:0022-1767
Container-title:The Journal of Immunology
language:en
Short-container-title:J.I.

Author:

Wu Chung-Yao,Hua Kuo-Feng,Hsu Wan-Han,Suzuki Yusuke^ORCID,Chu Lichieh Julie^ORCID,Lee Yu-Chieh,Takahata Akiko,Lee Sheau-Long,Wu Chia-Chao^ORCID,Nikolic-Paterson David J.,Ka Shuk-Man,Chen Ann

Publisher

The American Association of Immunologists

Subject

Immunology,Immunology and Allergy

Reference58 articles.

1. Controlled, prospective trial of steroid treatment in IgA nephropathy: a limitation of low-dose prednisolone therapy

2. Appearance of Compound K, a Major Metabolite of Ginsenoside Rb1 by Intestinal Bacteria, in Rat Plasma after Oral Administration. Measurement of Compound K by Enzyme Immunoassay.

3. Enzymatic formation of compound-K from ginsenoside Rb1 by enzyme preparation from cultured mycelia of Armillaria mellea.;Upadhyaya;J. Ginseng Res.,2016

4. Current Evaluation of the Millennium Phytomedicine- Ginseng (II): Collected Chemical Entities, Modern Pharmacology, and Clinical Applications Emanated from Traditional Chinese Medicine

5. Ginsenoside Metabolite Compound K Alleviates Adjuvant-Induced Arthritis by Suppressing T Cell Activation

Cited by 28 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Galectin-3 contributes to pathogenesis of IgA nephropathy;Kidney International;2024-07

2. Multi-layered effects of Panax notoginseng on immune system;Pharmacological Research;2024-06

3. Comprehensive Analysis of ceRNA Network and Immune Cell Infiltration Pattern of Autophagy-Related Genes in IgA Nephropathy;Kidney and Blood Pressure Research;2024-05-31

4. The SP1/SIRT1/ACLY signaling axis mediates fatty acid oxidation in renal ischemia–reperfusion-induced renal fibrosis;International Immunopharmacology;2024-05

5. Protopanaxadiol improves lupus nephritis by regulating the PTX3/MAPK/ERK1/2 pathway;Journal of Natural Medicines;2024-03-03